Lucentis Prefilled Syringe contains ranibizumab, a monoclonal antibody fragment (Fab) that targets and blocks vascular endothelial growth factor A (VEGF-A). VEGF-A is a protein responsible for the growth of abnormal blood vessels in the retina that leak fluid and cause vision loss. By inhibiting VEGF-A, Lucentis helps reduce swelling and prevents further damage to the macula — the part of the eye responsible for sharp central vision.
No shipping information available.
You can buy Lucentis Prefilled Syringe 10 mg/mL online with a valid prescription from a licensed healthcare provider.
Lucentis is used to treat wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and myopic choroidal neovascularization.
Lucentis is injected directly into the eye by an ophthalmologist under sterile conditions, typically once a month.
No. Lucentis must be administered by a trained healthcare professional to ensure safety and accuracy.
You may experience mild discomfort, redness, or blurred vision for a short time after the injection. Your doctor will monitor your eye to ensure normal healing.
Yes, many patients experience improved or stabilized vision after several months of treatment. Early intervention increases the likelihood of positive results.
Contact your ophthalmologist as soon as possible to reschedule your injection and maintain consistent treatment.
It should be used during pregnancy only if clearly needed and prescribed by a doctor. Discuss potential risks and benefits before treatment.
Keep them refrigerated between 2°C and 8°C, protected from light, and do not freeze.
Treatment duration depends on your condition and response. Some patients need ongoing monthly injections, while others may require fewer over time.
No rewards information available.
No doctor visit information available.